FDA releases new guidelines for popular sleeping aid pill - KFDA NewsChannel 10
After complaints of morning drowsiness and even several car accidents, the Food and Drug Administration is placing new guidelines on a popular sleeping aid - Ambien and its successors.
...
"The metabolism of any drug including alcohol is different in men and women," said Dr. Bharat Khandheria, an Associate Professor of Internal Medicine at the Texas Tech University Health Sciences Center. "And if your metabolism is slow, especially in women, then maybe a lot of the drug will be leftover in the morning."
Read the full story >>
Related Stories
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.
Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing
Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.
TTUHSC School of Nursing to Celebrate New YWCA Location
Community members in central Lubbock now have access to health care services and prenatal programs at one location inside the YWCA.
Recent Stories
New Permian Basin Chair Seeks to Develop International Hub for Rural Psychiatry
Rajendra Badgaiyan, M.D., joined the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine in November as a professor and Department of Psychiatry chair at the Permian Basin campus.
The ARRIVE Program: Offering a Brighter Future for the IDD Community
The ARRIVE Program provides a supported work context within the TTUHSC Occupational Therapy Department (OTD) for young adults with IDD to gain necessary skills.
Study Focuses on Resistance to Androgen Receptor-Targeted Therapy in Advanced Prostate Cancer
A TTUHSC research team led by Srinivas Nandana, Ph.D., and Manisha Tripathi, Ph.D., from the TTUHSC School of Medicine recently completed a study that focused on uncovering the mechanisms that drive the progression of prostate cancer.